NextPlat (NASDAQ:NXPL) Trading Up 6.5% – Still a Buy?

NextPlat Corp. (NASDAQ:NXPLGet Free Report)’s stock price traded up 6.5% during mid-day trading on Thursday . The company traded as high as $8.37 and last traded at $7.69. 59,910 shares traded hands during trading, an increase of 205% from the average session volume of 19,660 shares. The stock had previously closed at $7.22.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, NextPlat currently has a consensus rating of “Sell”.

Get Our Latest Report on NXPL

NextPlat Stock Performance

The stock’s 50-day simple moving average is $5.98 and its 200-day simple moving average is $5.92. The stock has a market cap of $17.85 million, a price-to-earnings ratio of -1.53 and a beta of 1.90. The company has a current ratio of 2.56, a quick ratio of 2.12 and a debt-to-equity ratio of 0.05.

NextPlat (NASDAQ:NXPLGet Free Report) last announced its earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share (EPS) for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.The business had revenue of $9.86 million for the quarter.

Institutional Trading of NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC purchased a new position in shares of NextPlat Corp. (NASDAQ:NXPLFree Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by institutional investors and hedge funds.

About NextPlat

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.

Featured Articles

Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.